PDL-1′s 3-year survival rates in cancer tissue in the positive and negative were 48.78 % (20/41) and 61.29 % (19/31), separately, and no distinct differences were presented between the two (p > 0.05), as manifested in Fig. 4. This evidence concerns the gene CD274 and cancer.